Acute stroke therapy. Current developments;Akuttherapie des schlaganfalls. Was gibt es neues?

Nervenarzt

Volumn 78, Issue 10, 2007, Pages 1147-1154

  Steiner, T ^a   Juttler E ^a   Ringleb, P ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Cerebral infarction; Decompressive surgery; Desmoteplase; Hemostasis; Intracerebral hemorrhage; Malignant middle cerebral artery infarction; Recombinant activated factor VIIa; Thrombolysis; Time window

Indexed keywords

BARBITURIC ACID DERIVATIVE; DESMOTEPLASE; FIBRINOLYTIC AGENT; GLYCEROL; HEMOSTATIC AGENT; HEPARIN; HETASTARCH; MANNITOL; PLACEBO; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; AUSTRALIA; BLOOD CLOT LYSIS; BRAIN EDEMA; BRAIN HEMORRHAGE; CEREBRAL ARTERY DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CRANIECTOMY; DECOMPRESSION SURGERY; DISEASE SEVERITY; EUROPE; FIBRINOLYTIC THERAPY; HEMATOMA; HUMAN; INTENSIVE CARE; MORTALITY; NORTH AMERICA; PATIENT SELECTION; PROGNOSIS; RISK REDUCTION; STROKE; THERAPY EFFECT; TREATMENT OUTCOME;

ACUTE DISEASE; BRAIN EDEMA; CEREBRAL HEMORRHAGE; CEREBRAL INFARCTION; CLINICAL TRIALS, PHASE III AS TOPIC; DECOMPRESSION, SURGICAL; FACTOR VIIA; FOLLOW-UP STUDIES; HEMOSTASIS; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; MULTICENTER STUDIES AS TOPIC; PLASMINOGEN ACTIVATORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECOMBINANT PROTEINS; SURVIVAL RATE; THROMBOLYTIC THERAPY;

EID: 35748966998     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-007-2352-7     Document Type: Article

References (30)

1. Adams HP Jr, Nibbelink DW, Torner JC, Sahs AL (1981) Antifibrinolytic therapy in patients with aneurysmal subarachnoid hemorrhage. A report of the cooperative aneurysm study. Arch Neurol 38: 25-29
2. Balzer B, Stober T, Huber G, Schimrigk K (1987) Der raumfordernde Hirninfarkt. Nervenarzt 58: 689-691
3. Broderick J, Brott T, Duldner JE, Tomsick T, Huster G (1993) Volume of intracrerbral hemorrhage: a powerful and easy-to-use predictor of 30-day mortality. Stroke 24: 987-993
4. Brott T, Broderick J, Kothari R et al. (1997) Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 28: 1-5
5. Fujii Y, Tanaka R, Takeuchi S et al. (1994) Hematoma enlargement in spontaneous intracerebral hemorrhage. J Neurosurg 80: 51-57
6. Fujitsu K, Muramoto M, Ikeda Y et al. (1990) Indications for surgical treatment of putaminal hemorrhage. Comparative study based on serial CT and time-course analysis. J Neurosurg 73: 518-525
7. Furlan AJ, Eyding D, Albers GW et al. (2006) Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 37: 1227-1231
8. Georgiadis D, Schwab S (2005) Hypothermia in acute stroke. Curr Treat Options Neurol 7: 119-127
9. Goldberg M (2007) Stroke Trials Registry. Internet Stroke Center web site. www.strokecenter.org
10. Gregson BA, Mendelow AD (2005) Surgical trial in lobar intracerebral hemorrhage (STICH II). In: Proceedings of the Scottish and NewCastle Neursurgical Research Network, S 7-10
11. Hacke W, Albers G, Al-Rawi Y et al. (2005) The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): A phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 36: 66-73
12. Hacke W, Schwab S, Horn M et al. (1996).,Malignant" middle cerebral artery infarction. Clinical course and prognostic signs. Arch Neurol 53: 309-315
13. Hoffman M, Monroe DM, Roberts HR (1998) Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII. Blood Coagul Fibrinolysis [Suppl 1] 9: 61-65
14. Hoffman M, Monroe DM (2001) A cell-based model of hemostasis. Thromb Haemost 85: 958-965
15. Hofmeijer J, Worp HB van der, Kappelle LJ (2003) Treatment of space-occupying cerebral infarction. Crit Care Med 31: 617-625
16. Kassell NF, Haley EC, Torner JC (1986) Antifibrinolytic therapy in the treatment of aneurysmal subarachnoid hemorrhage. Clin Neurosurg 33: 137-145
17. Kazui S, Naritomi H, Yamamoto H et al. (1996) Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course. Stroke 27: 1783-1787
18. Mayer S, Brun N, Broderick J et al. (2005) Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage. Stroke 36: 74-79
19. Mayer S, Brun N, Begtrup K et al. (2005) Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 352: 777-785
20. Piriyawat P, Morgenstern LB, Yawn D et al. (2004) Treatment of acute intracerebral hemorrhage with e-aminocaproic acid - a pilot study. Neurocrit Care 1: 47-51
21. Puetz V, Campos CR, Eliasziw M et al. (2007) Assessing the benefits of hemicraniectomy: what is a favourable outcome? Lancet Neurol 6: 580
22. Roos Y (2000) Antifibrinolytic treatment in subarachnoid hemorrhage: a randomized placebo-controlled trial. STAR Study Group. Neurology 54: 77-82
23. Roos YB, Rinkel GJ, Vermeulen M et al. (2003) Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev: CD001245
24. Schwab S, Steiner T, Aschoff A et al. (1998) Early hemicranectomy in patients with complete middle cerebral artery infarction. Stroke 29: 1888-1893
25. Schwarz S, Georgiadis D, Schwab S et al. (2002) Aktuelle Konzepte der Intensivtherapie des raumfordernden Mediainfarkts. Nervenarzt 73: 508-518
26. Steiner T, Ringleb P, Hacke W (2001) Treatment options for large hemispheric stroke. Neurology [Suppl 2] 57: S61-S68
27. Steiner T, Seremetis S, Skolnick BE, Kruse P (2004) Safety of recombinant coagulation factor VII in patients with acute intracerebral hemorrhage. Cerebrovasc Dis 17: 67
28. Vahedi K, Hofmeijer J, Juettler E et al. for the DECIMAL, DESTINY, and HAMLET investigators (2007) Early decompressive surgery in malignant middle cerebral artery infarction: a pooled analysis of three randomised controlled trials. Lancet Neurol 6: 215-222
29. Vahedi K, Hofmeijer J, Juettler E et al. for the DECIMAL, DESTINY, and HAMLET investigators (2007) Assessing the benefits of hemicraniectomy: what is a favourable outcome? - Authors' reply. Lancet Neurol 6: 580-581
30. Vujkovac B, Sabovic M (2000) Treatment of subdural and intracerebral haematomas in a haemodialysis patient with tranexamic acid. Nephrol Dial Transplant 15: 107-109